Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including lenacapavir—HIV’s ability to evolve resistance to the breakthrough antiviral.

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

A new study, by Dr. Michael Martynowycz from the Hauptman-Woodward Medical Research Institute (HWI), and researchers at UCLA, and HHMI, reveals how viruses hijack cellular condensates to assemble and ...

Viruses are tiny agents that can infect a variety of living organisms, including bacteria, plants, and animals. Like other viruses, the dengue virus is a microscopic structure that can only replicate ...

Researchers found that Zika virus induces cells to create connections, called tunneling nanotubes, that may enable the virus to replicate and spread from mother to fetus. UNIVERSITY PARK, Pa. — In ...

Single-cell analysis helps uncover how the BK virus replicates, opening the door to new drug targets. BK polyomavirus (BKPyV) is a major cause of kidney transplant failure. Without a complete ...

A 13-year-old girl in British Columbia who was hospitalized with bird flu for several weeks late last year harbored a mutated version of the virus, according to a report published this week in the New ...

In a groundbreaking discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have identified a never-before-seen mechanism that enables the human ...

New findings reveal the presence of replication-competent Oropouche virus in semen, posing fresh questions about sexual transmission risks and public health safety. Research Letter: ...